Immunitybio Inc (IBRX) valuation · rev $113.3M
Immunitybio Inc (IBRX) rev $113.3M.
| Metric | Value |
|---|---|
| Market cap | $7.88B |
| Revenue | $113.3M |
| P/S | 69.5 |
IBRX valuation FAQ
What is IBRX's market cap?
Immunitybio Inc (IBRX) market cap is $7.88B on the latest cached fundamentals snapshot.
What is IBRX's latest revenue?
Latest cached Immunitybio Inc (IBRX) revenue was $113.3M. Statements: https://lician.com/financials/ibrx
What is IBRX's price-to-sales ratio?
Immunitybio Inc (IBRX) price-to-sales (P/S) is 69.5, cached market cap $7.88B divided by revenue $113.3M.
How many IBRX valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Immunitybio Inc (IBRX): Market cap, Revenue, and P/S.
Where is IBRX valuation listed?
Cached valuation multiples for Immunitybio Inc (IBRX) are listed at https://lician.com/valuation/ibrx.
Not investment advice. Cached rows, not a live tape.